Navigation Links
HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
Date:2/26/2008

NEW YORK and DALLAS, Feb. 26 /PRNewswire/ -- HealthpointCapital, LLC. ("HealthpointCapital") announced today that it has appointed Dr. Stephen H. Hochschuler as Clinical Advisor to the Firm. HealthpointCapital is a values- driven, research-based private equity firm exclusively focused on orthopedic and dental device companies. Dr. Hochschuler is the co-founder of the Texas Back Institute, Chairman of Texas Back Institute Holdings and Chairman of the Board, a founding member and former President of the Spine Arthroplasty Society and a board certified orthopedic surgeon.

"We are very pleased that Dr. Hochschuler is joining us as Clinical Advisor," stated Mortimer Berkowitz III, President of HealthpointCapital. "Investing in companies that improve patient care is central to HealthpointCapital investment thesis which means we are continually deepening our scientific knowledge and relationships in order to build companies that offer the most innovative products and best clinical outcomes. Dr. Hochschuler's unparalleled understanding of medical science and advanced technologies will allow us to better deliver to the marketplace and create value for our investors."

Dr. Stephen H. Hochschuler stated, "I am pleased to be working more closely with HealthpointCapital. The firm's research and investment teams have demonstrated their commitment to developing strategies and organizations that are responsive surgeons' needs through innovative product development. I am confident that this partnership will lead to important advancements in the orthopedic device industry."

For More Information:

Lauren Uzdienski

HealthpointCapital, LLC

212.935.7780

http://www.healthpointcapital.com

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital has $650 million of institutional capital under management. The firm believes it is the only of its kind to focus exclusively on late stage opportunities in the $30 billion worldwide orthopedic and dental device industry. The firm's professionals have a cumulative 85 years of experience in healthcare investing and technology. The firm also publishes extensively on musculoskeletal technologies and industry activities on its dedicated research site at http://www.healthpointcapital.com


'/>"/>
SOURCE HealthpointCapital, LLC.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints New Chief Financial Officer
2. Ceremed Appoints Vice President for Sales and Business Development
3. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
4. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
5. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
6. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
7. Deerfield Spa Appoints New Fitness Director
8. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
9. P\S\L Group appoints Paul Barnes as Group President P\S\L Research
10. AtriCure Appoints Mark A. Collar to its Board of Directors
11. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 2016 , ... CloudLIMS.com, a class-leading provider of Laboratory Management ... Lite helps biobanks, clinical, research and testing laboratories keep track of their biospecimens, ... is a faster and a more efficient product, allowing batch processing of data, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House ... this current generation fits into Bible Prophecy. Yisrayl says this generation, known as the ... this conclusion, showing how the details line up exactly with Bible Prophecy – a ...
(Date:12/2/2016)... Pass, OR (PRWEB) , ... December 02, 2016 ... ... Wein, Medical Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s ... host of The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
(Date:11/30/2016)... PALMYRA, Wisconsin (PRWEB) , ... November 30, 2016 ... ... inclusion in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of ... consecutive year on the list, having ranked from 2008-2016. In addition, Standard Process ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... community that the FDA Binding Guidance goes into effect next month. Sponsors whose ... in the FDA Data Standards Catalog. The current FDA Data Standards Catalog specifies ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016   CytoSorbents Corporation (NASDAQ: ... European Union approved CytoSorb ® cytokine adsorber to ... worldwide, announced that Dr. Phillip Chan , Chief ... LD Micro Main Event investor conference held from ... Luxe Sunset Boulevard Hotel in Los Angeles, ...
(Date:12/2/2016)... Research and Markets has announced the addition of Jain ... and Companies" to their offering. ... , , Drug ... market value of drug delivery technologies and the anticancer drugs are ... to organs involved and the types of cancer as well as ...
(Date:12/2/2016)... Around the corners of world, cancer has infused itself ... over earth. Cancer has become one of those nightmares ... this is because of the increasing incidence rates and ... increase in global cancer incidence with its associated morbidity ... treatment, there is increasing interest in this stringent disease. ...
Breaking Medicine Technology: